Patents

Search tools Text Classification Chemistry Measure Numbers Full documents Title Abstract Claims All Any Exact Not Add AND condition These CPCs and their children These exact CPCs Add AND condition
Exact Exact Batch Similar Substructure Substructure (SMARTS) Full documents Claims only Add AND condition Add AND condition
Application Numbers Publication Numbers Either Add AND condition

Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Classifications

C07D295/096 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
View 20 more classifications

Landscapes

Chemical & Material Sciences Organic Chemistry
Show more

IL126070A0

Israel

Find Prior Art Similar
Other languages
English
Worldwide applications
1996 SE 1997 ZA IL DE EP JP SK NZ TR CZ EE BR AT PL AU US CA IL KR CN HU WO AR ID HR AR 1998 IS NO YU 2000 US
Application IL12607097A events
1997-03-20
Application filed by Astra Ab
1999-05-09
Publication of IL126070A0
Info
Patent citations (14)
Cited by (24)
Similar documents
Priority and Related Applications
External links
Espacenet
Global Dossier
Discuss

Patent Citations (14)

Publication number Priority date Publication date Assignee Title
Family To Family Citations
DE3919624A1 * 1989-06-15 1990-12-20 Boehringer Ingelheim Kg Neue 2,5-diaminotetraline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DK0712837T3 * 1991-02-08 2000-11-20 Lilly Co Eli Ringsubstituerede 2-amino-1,2,3,4-tetrahydronaphtalener og 3-aminochromaner
GB9119920D0 * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
GB9119932D0 * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
EP0533268B1 * 1991-09-18 2001-08-16 Glaxo Group Limited Benzanilide derivatives as 5-HT1D antagonists
DK148392D0 * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
GB2273930A * 1992-12-30 1994-07-06 Glaxo Group Ltd Benzanilide derivatives
EP0689536B1 * 1993-03-16 2001-05-23 Pfizer Inc. Naphthalene derivatives
SE9301732D0 * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
WO1995011243A1 * 1993-10-19 1995-04-27 Smithkline Beecham Plc Benzanilide derivatives as 5ht-1d receptor antagonists
SE9702799D0 * 1997-07-25 1997-07-25 Astra Ab New compounds
SE9703375D0 * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703376D0 * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703374D0 * 1997-09-18 1997-09-18 Astra Ab A new combination
* Cited by examiner, † Cited by third party

Cited By (24)

Publication number Priority date Publication date Assignee Title
Family To Family Citations
SE9900190D0 1999-01-22 1999-01-22 Astra Ab New compounds
SE9702799D0 1997-07-25 1997-07-25 Astra Ab New compounds
SE9703374D0 * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703379D0 * 1997-09-18 1997-09-18 Astra Ab New compounds
SE9703375D0 * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703376D0 * 1997-09-18 1997-09-18 Astra Ab A new combination
DK0952154T3 1998-04-16 2004-12-13 Pfizer Prod Inc N-acyl- og N-aroylaralkylamider
SE0002729D0 * 2000-07-20 2000-07-20 Astrazeneca Ab Novel compound form
CN100509794C 2001-01-16 2009-07-08 阿斯特拉曾尼卡有限公司 治疗性杂环化合物
IL156602A0 2001-01-16 2004-01-04 Astrazeneca Ab Therapeutic chromone compounds
ES2323451T7 2001-07-20 2011-08-01 Psychogenics Inc. Tratamiento para el trastorno de hiperactividad con deficit de atencion.
SE0301798D0 * 2003-06-19 2003-06-19 Astrazeneca Ab New use IV
SE0301794D0 * 2003-06-19 2003-06-19 Astrazeneca Ab New use III
HRP20100181T1 * 2004-12-21 2010-05-31 F. Hoffmann - La Roche Ag Derivati tetralina i indana i njihove upotrebe
WO2007108742A1 * 2006-03-17 2007-09-27 Astrazeneca Ab Novel tetralins as 5-ht6 modulators
WO2008130322A1 * 2007-04-23 2008-10-30 Astrazeneca Ab Novel 5-heterocyclyl-chromane derivatives for the treatment of pain
WO2008130319A2 * 2007-04-23 2008-10-30 Astrazeneca Ab Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
SA08290245B1 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
WO2008130323A1 * 2007-04-23 2008-10-30 Astrazeneca Ab Novel 8-piperazine-tetrahydronaphtalene derivatives for the treatment of pain
WO2008130321A2 * 2007-04-23 2008-10-30 Astrazeneca Ab Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
EP2098511A1 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
JP6888827B2 * 2015-05-19 2021-06-16 ノースイースタン ユニバーシティ 末梢におけるセロトニン受容体をモジュレートするための化合物または方法
WO2020183011A1 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
CN118121595B * 2024-05-06 2024-08-16 广州市朝利良生物科技有限公司 化合物eh-p005j在制备促伤口愈合药物中的用途
* Cited by examiner, † Cited by third party, ‡ Family to family citation

Similar Documents

Publication Publication Date Title
ZA977687B 1999-03-01 Substituted 6,5-hetero-bicyclic derivatives
IL128049A0 1999-11-30 Substituted 6,6-hetero-bicyclic derivatives
ZA986588B 1999-01-25 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
GB2319250B 1999-01-27 Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
PL331602A1 1999-08-02 Pyrido- or pyrimido-substituted 6,6- or 6,7-bicyclic derivatives
IL141908A0 2002-03-10 1,4-benzodiazepine derivatives
IL126070A0 1999-05-09 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
IL126624A0 1999-08-17 3-descladinose-2, 3-anhydroerythromycin derivatives
HU9600871D0 1996-05-28 New 2,3-benzodiazepine derivatives
PL330141A1 1999-04-26 Novel derivatives of 10,11-dihydro-10-oxo-5h-dibezyl(b,f)-azepin-5-carboxagmide
SG70589A1 2000-02-22 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
HK1015782A 1999-10-22 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
IL132162A0 2001-03-19 2, 3-Epoxypropionamide derivatives
IL132162A 2000-08-13 2,3-epoxypropionamide derivatives
IL129029A0 2000-02-17 8(9)-Dehydroestradiol derivatives
ZA965384B 1997-01-24 4-Amino-5-oxy-2,6,6-trimethyl-2-cycloheptene compounds
SI0920429T1 2003-06-30 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
HUP9903001A3 2000-06-28 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
IL119853A0 1997-03-18 Aminoindan derivatives

Priority And Related Applications

Applications Claiming Priority (2)

Application Filing date Title
SE9601110A 1996-03-22 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
PCT/SE1997/000469 1997-03-20 Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Concepts

machine-extracted
Download Filter table
Name Image Sections Count Query match
tetralin title 1 0.000
Show all concepts from the description section
Data provided by IFI CLAIMS Patent Services